Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. - Dziennis S; Mader S; Akiyoshi K; Ren X; Ayala P; Burrows GG; Vandenbark AA; Herson PS; Hurn PD; Offner HA (Metabolic brain disease, 2011)